The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArmadale Capital Regulatory News (ACP)

Share Price Information for Armadale Capital (ACP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.725
Bid: 0.70
Ask: 0.75
Change: 0.00 (0.00%)
Spread: 0.05 (7.143%)
Open: 0.725
High: 0.725
Low: 0.725
Prev. Close: 0.725
ACP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Sep 2023 07:00

RNS Number : 0663O
Armadale Capital PLC
29 September 2023
 

Armadale Capital Plc / Index: AIM / Epic: ACP / Sector: Investment Company

29 September 2023

Armadale Capital Plc

('Armadale' the 'Company' or the 'Group')

Interim Results

 

Armadale, the AIM quoted investment company focused on natural resource projects in Africa, is pleased to announce its unaudited interim results for the six months ended 30 June 2023.

 

Highlights

 

During the half year Armadale has made further progress towards commercial production at the Mahenge Liandu Project in Tanzania.

· Armadale continue to advance the FEED study in preparation for obtaining project financing. This information will enhance the detail in the Definitive Feasibility Study.

· Armadale continued to collect environmental baseline data as is required for the compliance of the mining lease and to assist in the design and planning of the proposed mining operations. In addition, the base line data for temperature, pressure, wind, moon phase, humidity, solar radiation, rainfall and stream flow data assists the local community to have access to regional weather data for local planning requirements in the Mahenge region.

· Logistics routes for the product were assessed to determine the optimum methods to ensure the final product will enter the market at the desired price level.

The Group is continuing discussions with several potential financing partners regarding the debt and equity funding required for project development. The significantly improved market fundamentals for graphite concentrates has lead to increased interest from stakeholders capable of providing long-term project finance. Armadale continued its ongoing review of its quoted equity portfolio, where the Directors believe there are opportunities for capital gains, and made a number of acquisitions of quoted companies in the resources sector.

Armadale also continued to actively review other investment opportunities for mineral exploration in Africa.

During the period, a further £60,000 was spent on the project and the Company also expanded its portfolio of passively managed investments, spending £587,000 on three new holdings in listed resource companies. The portfolio performed well during the period, increasing in overall market value by £456,000 net. At 30 June 2023 the Company had cash of £300,000 (with and average monthly cash burn of about £20,000 including annual audit costs) and listed investments worth £1,593,000.

 

 

FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 30 JUNE 2023

 

Condensed Consolidated Statement of Comprehensive Income

For the six months ended 30 June 2023

 

 

 

Unaudited

Six months ended

 

 

30 June

2023

£'000

30 June

2022

£'000

Administrative expenses

(165)

(151)

Change in fair value of investments

456

(1)

Profit/(loss) before taxation

291

(152)

Taxation

-

-

Profit/(loss) after taxation

291

(152)

Other comprehensive income/(loss)

 

 

 

Items that may be reclassified to profit or loss:

Exchange differences on translating foreign entities

24

(57)

Total comprehensive income/(loss) attributable to equity holders of the parent company

 

315

(209)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pence

Pence

Earnings/(loss) per share attributable to equity holders of the parent company (note 3)

Basic and fully diluted

0.05

 

 

(0.03)

 

Consolidated Statement of Financial Position

At 30 June 2023

 

 

Unaudited

Audited

 

30 June 2023

30 June 2022

31 December 2022

 

 

£'000

£'000

£'000

Assets

Non-Current assets

Exploration and evaluation assets

5,550

5,010

5,483

Investments

1,593

79

562

7,143

5,089

6,045

Current assets

Trade and other receivables

137

60

150

Cash and cash equivalents

300

1,723

1,046

437

1,783

1,196

Total assets

 

7,580

6,872

7,241

 

 

Equity and liabilities

Equity

 

Share capital

3,324

3,321

3,324

Share premium

25,153

25,076

25,153

Shares to be issued

286

286

286

Share option and warrant reserve

362

610

362

Foreign exchange reserve

342

9

318

Retained earnings

(21,988)

(22,473)

(22,279)

Total equity

7,479

6,829

7,164

Current liabilities

 

Trade and other payables

 

101

43

77

 

Total equity and liabilities

 

7,580

6,872

7,241

 

 

 

 

 

 

 

 

 

Unaudited Consolidated Statement of Changes in Equity

For the period ended 30 June 2023

 

Share

Capital

£'000

Share Premium

£'000

Shares to be

Issued

£'000

Share Option Reserve

£'000

Foreign Exchange Reserve

£'000

Retained Earnings

£'000

Total

 

£'000

 

 

 

 

 

 

 

 

Balance 1 January 2022

3,275

23,906

286

925

66

(22,636)

5,822

Loss for the year

-

-

-

-

-

(206)

(206)

Other comprehensive income

-

-

-

-

252

-

252

Total comprehensive income for the year

 

-

 

-

 

-

 

-

252

(206)

46

 

Issue of shares

49

1,247

-

-

-

-

1,296

Transfer on exercise and expiry of warrants

-

-

-

(563)

-

563

-

Total other movements

49

1,247

-

(563)

-

563

1,296

Balance 31 December 2022

3,324

25,153

286

362

318

(22,279)

7,164

 

 

Profit for the period

-

-

-

-

-

291

291

Other comprehensive income

-

-

-

-

24

-

24

Total comprehensive income for the period

-

-

-

-

24

291

315

Balance 30 June 2023

3,324

25,153

268

362

342

(21,988)

7,479

 

 

The following describes the nature and purpose of each reserve within shareholders' equity:

 

Reserve Description and purpose

Share capital Amount subscribed for share capital at nominal value

Share premium Amount subscribed for share capital in excess of nominal value, net of allowable expenses

Shares to be issued Share capital to be issued in connection with historical acquisition

Share option and warrant reserve Cumulative charge recognised under IFRS2 in respect of share-based payment awards

Foreign exchange reserve Gains/losses arising on re-translating the net assets of overseas operations into sterling

Retained earnings Cumulative net gains and losses recognised in the statement of comprehensive income

 

 

 

Consolidated Statement of Cash Flows

For the period ended 30 June 2023

 

 

Unaudited

Audited

 

Six Months ended

Year ended

 

30 June 2023

30 June 2022

31 December 2022

£'000

£'000

£'000

 

 

 

Cash flows from operating activities

Profit/(loss) before taxation

291

(152)

(206)

Change in fair value of investments

(456)

1

(102)

 

(165)

(151)

(308)

Changes in working capital

Receivables

13

30

(11)

Payables

24

(31)

12

Net cash used in operating activities

(128)

(152)

(307)

 

Cash flows from investing activities

Expenditure on exploration and evaluation assets

(60)

(345)

(518)

Purchase of listed investments

(587)

(411)

Sale of listed investments

29

58

89

Net cash used in investing activities

(618)

(287)

(840)

 

Cash flows from financing activities

Proceeds from share issues

-

1,276

1,307

Net cash from financing activities

-

1,276

1,307

Net (decrease)/increase in cash and cash equivalents

(746)

837

160

Cash and cash equivalents at 1 January 2023

1,046

886

886

Cash and cash equivalents at 30 June 2023

300

1,723

1,046

 

 

 

 

Notes to the unaudited condensed consolidated financial statements

For the period ended 30 June 2023

 

 

1. Incorporation and principal activities

Country of incorporation

 

Armadale Capital Plc was incorporated in the United Kingdom as a public limited company on 19 August 2005. Its registered office is 1 Arbrook Lane, Esher, Surrey, KT10 9EG.

 

Principal activities

 

The principal activity of the Group during the period was that of an investment company.

 

2. Accounting policies

 

2.1. Statement of compliance

 

The financial information for the six months ended 30 June 2022 and 30 June 2021 is unaudited and does not constitute the Group's statutory financial statements for those periods within the meaning of Section 434 of the Companies Act 2006. The comparative financial information for the year ended 31 December 2021 has been derived from the Annual Report and Accounts, which were approved by the Board of Directors on 20 May 2022 and delivered to the Registrar of Companies. The report of the Auditors on those accounts was unqualified and did not contain any statement under Section 498 of the Companies Act 2006.

 

This condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union. This condensed set of financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2021 which have been prepared in accordance with International Financial Reporting Standards (IFRSs) as adopted by the United Kingdom.

 

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 31 December 2021 as described in those annual financial statements.

 

In respect of new financial reporting standards which came into effect for reporting periods beginning on 1 January 2022, the Directors consider that their implementation has no material effect on the financial information presented in this statement.

 

2.2. Going Concern

 

The financial statements have been prepared on the going concern basis as, in the opinion of the Directors, there is a reasonable expectation that the Group will continue in operational existence for the foreseeable future. The Company's ability to continue as a going concern and to achieve its long term strategy of developing its exploration projects is dependent on further fundraising. At 30 June 2023, the Group had cash of £300,000 and listed investments with a value of £1,593,000.

 

2.3. Exploration and evaluation assets

 

These assets are recorded at cost and are amortised over their expected useful life on a pro rata basis of actual production for the period to expected total production.

 

2.4. Investments

 

Investments are stated at fair value.

 

 

3. Earnings/(loss) per share

 

The calculation of earnings per share is based on a profit of £291,000 (2022, loss of £152,000) and on 587,529,895 (2022, 560,588,302) Ordinary Shares, being the weighted average number of Ordinary Shares in issue during the period.

 

For the period ended 30 June 2022, there was no difference between basic loss per share and diluted loss per share as the Group reported a loss.

 

 

**ENDS**

 

For further information, please visit the Company's website www.armadalecapitalplc.com, follow Armadale on Twitter @ArmadaleCapital or contact:

 

Enquiries:

Armadale Capital Plc

Tim Jones, Company Secretary

+44 (0)20 7236 1177

Nomad and broker: Cavendish Capital Markets Limited

Simon Hicks / Seamus Fricker

+44 (0)20 7220 0500

 

 

The Company also announces that its Nominated Adviser and Broker, finnCap Ltd, has now changed its name to Cavendish Capital Markets Limited following completion of its own corporate merger.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

More information can be found on the website www.armadalecapitalplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BLGDCLDDDGXI
Date   Source Headline
24th Apr 20248:30 amRNSProposed Investment, Subscription & Board Changes
27th Feb 20242:45 pmRNSMahenge Project Update
19th Dec 202311:15 amRNSBlock listing Interim Review
29th Sep 20237:00 amRNSHalf-year Report
20th Jun 202310:38 amRNSResult of AGM
19th Jun 20237:00 amRNSBlock listing Interim Review
12th May 20237:00 amRNSFinal Results and Notice of AGM
13th Feb 20239:00 amRNSMahenge Project Update
19th Dec 20227:00 amRNSBlock listing Interim Review
29th Sep 20227:00 amRNSHalf-year Report
20th Jun 202210:45 amRNSResult of AGM
17th Jun 20223:30 pmRNSBlock listing Interim Review
23rd May 20227:00 amRNSFinal Results and Notice of AGM
3rd May 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Apr 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
17th Mar 20223:20 pmRNSHolding(s) in Company
11th Mar 20222:45 pmRNSDirector/PDMR Shareholding and TVR
8th Feb 20228:15 amRNSAdvancing Mining Lease and Expanded Footprint
17th Dec 20217:00 amRNSBlock listing Interim Review
15th Dec 20219:30 amRNSManagement Team Enhanced With Key Appointment
1st Dec 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Nov 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Oct 20217:00 amRNSIssue of equity under block admission arrangements
29th Sep 20217:00 amRNSHalf-year Report
3rd Sep 20219:00 amRNSMahenge Mining Licence Granted
31st Aug 20217:00 amRNSNotification of Changes in Major Holdings
6th Aug 20211:25 pmRNSConversion of Loan Notes and Director Shareholding
28th Jun 202112:40 pmRNSBlock Admission & TVR
28th Jun 202112:18 pmRNSAGM Statement
17th Jun 20217:00 amRNSBlock listing Interim Review
28th May 20213:45 pmRNSSubscription and Investment Portfolio Update
28th May 20213:18 pmRNSFinal Results And Notice of AGM
22nd Apr 202110:00 amRNSCompletion of Test Work Program
12th Apr 20219:20 amRNSChange of Adviser
30th Mar 20219:58 amRNSESIA Approval from NEMC of Tanzania
24th Mar 20217:35 amRNSBoard Change
8th Mar 202112:36 pmRNSNotification of Changes in Major Holdings
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 202111:00 amRNSArmadale Reports Successful Chinese EPC Test-Work
11th Jan 202111:00 amRNSCSIRO Graphite Test Work Results
17th Dec 20207:00 amRNSBlock listing Interim Review
24th Nov 202012:03 pmRNSTest-Work Commenced with Leading EPC Contractor
20th Nov 20204:41 pmRNSSecond Price Monitoring Extn
20th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 202010:00 amBUSMahenge Graphite Project Update
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:36 pmRNSPrice Monitoring Extension
29th Sep 20208:46 amBUSHalf-year Report
8th Sep 202012:45 pmBUSEnvironmental and Social Impact Assessment Submitted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.